Mark Hensley
Corporate Officer/Principal en VELOXIS PHARMACEUTICALS A/S .
Perfil
Mark Hensley is currently working as the Chief Commercial Officer at Veloxis Pharmaceuticals A.
He started this position in 2019.
Mr. Hensley completed his undergraduate degree at the University of North Texas.
Cargos activos de Mark Hensley
| Empresas | Cargo | Inicio |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03/01/2019 |
Formación de Mark Hensley.
| University of North Texas | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Hensley
